GoodRx Holdings, Inc. - Class A Common Stock (NQ:GDRX)

3.375 +0.095 (+2.90%)

Delayed Quote Updated: 10:49 AM EDT, Oct 5, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about GoodRx Holdings, Inc. - Class A Common Stock

< Previous 1 2

...

16 17 18 19 20 21 22 23 Next >

GoodRx Announces Date for First Quarter 2022 Earnings Release and Conference Call

April 11, 2022

From GoodRx

Via Business Wire

Benzinga's Top Ratings Upgrades, Downgrades For April 7, 2022 ↗

April 07, 2022

Upgrades

Via Benzinga

34 Public Companies That Made Time's 100 Most Influential For 2022: AMC, Disney, Ford And More ↗

March 31, 2022

Time announced this week its annual 100 Most Influential Companies list. Here’s a look at the publicly traded companies that made the list. What Happened: The 2022...

Via Benzinga

20 Stocks Moving Toward VWAP Breakout: GameStop, Roku, Moderna And More ↗

March 29, 2022

Volume-weighted average price, or VWAP, is the ratio of total volume traded divided by the total volume traded for a chosen time frame. VWAP is an important indicator for intraday trading, as it...

Via Benzinga

Benzinga's After-Hours Movers & News ↗

March 24, 2022

Benzinga’s “After-Hours Movers & News” highlights the biggest movers of the day. The information on the price action is collected using Benzinga Pro's...

Via Benzinga

Pharmacy Giant Files Patent to Join the Metaverse

March 23, 2022

FN Media Group Presents Microsmallcap.com Market Commentary New York, NY – March 23, 2022 – The Metaverse could soon have its own pharmacy after CVS revealed its plans to sell virtual goods and provide...

Via FinancialNewsMedia

Topics Intellectual Property

Where GoodRx Holdings Stands With Analysts ↗

March 17, 2022

Analysts have provided the following ratings for GoodRx Holdings (NASDAQ:GDRX) within the last quarter: Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish...

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For March 15, 2022 ↗

March 15, 2022

Upgrades For Turquoise Hill Resources Ltd (NYSE:TRQ), BMO Capital upgraded the previous rating of Underperform to Market Perform. Turquoise Hill Resources earned $0.78 in the...

Via Benzinga

Here's How Much You Could Buy With These CEOs' And Other C-Level Executives' Yearly Compensation ↗

March 13, 2022

The Economic Policy Institute (EPI) estimates that CEO compensation has grown 1,322% since 1978, while typical worker compensation has risen just 18%. In 2020, CEOs of the top 350...

Via Benzinga

TherapeuticsMD Shares Soars After VitaCare Divestiture In $150M Deal ↗

March 07, 2022

TherapeuticsMD Inc (NASDAQ: TXMD) has agreed to divest its VitaCare Prescription Services business to GoodRx Holdings Inc (NASDAQ: GDRX) for $150 million...

Via Benzinga

Mid-Afternoon Market Update: U.S. Stocks Extend Losses; Dow Dips 750 Points ↗

March 01, 2022

U.S. stocks extended losses toward the end of trading, with the Dow Jones tumbling 750 points on Tuesday. The Dow traded down 2.22% to 33,139.00 while the NASDAQ fell 1.66% to 13,...

Via Benzinga

Sea Limited News: Why Is SE Stock Dropping Today? ↗

March 01, 2022

Sea Limited (SE) stock is on the move today as investors react to the internet company's earnings report for the fourth quarter of 2021.

Via InvestorPlace

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

March 01, 2022

Gainers Avenue Therapeutics (NASDAQ:ATXI) shares rose 172.1% to $0.92 during Tuesday's regular session. As of 12:30 EST, this security is trading at a volume of 157.8...

Via Benzinga

Stocks That Hit 52-Week Lows On Wednesday ↗

March 02, 2022

Wednesday's session saw 107 companies set new 52-week lows. Points of Interest From Today's 52-Week Lows: Citigroup (NYSE:C) was the largest company by...

Via Benzinga

80 Biggest Movers From Yesterday ↗

March 02, 2022

Gainers Avenue Therapeutics, Inc. (NASDAQ: ATXI) jumped 78.5% to close at $0.6066 on Tuesday after jumping 36% on Monday. CTI BioPharma Corp. (NASDAQ: CTIC) surged 63...

Via Benzinga

GoodRx Plunges As Q4 Fall Short Of Expectations, Analysts Cut Price Target ↗

March 01, 2022

Consumer-focused digital healthcare, GoodRx Holdings Inc (NASDAQ: GDRX) shares are plunging after the company's Q4 FY21 earnings came in below expectations....

Via Benzinga

COIN Stock Price Predictions: How Much Higher Can Coinbase Go? ↗

March 01, 2022

Coinbase (COIN) stock is getting a boost today and we're diving into recent price predictions for an idea of how high the shares could go.

Via InvestorPlace

Mid-Day Market Update: Crude Oil Jumps 9%; GoodRx Holdings Shares Plunge ↗

March 01, 2022

U.S. stocks remained lower midway through trading on Tuesday, amid the ongoing Russia-Ukraine conflict. The Dow traded down 1.17% to 33,497.30 while the NASDAQ fell 0.40% to 13,...

Via Benzinga

44 Stocks Moving In Tuesday's Mid-Day Session ↗

March 01, 2022

Gainers Avenue Therapeutics, Inc. (NASDAQ: ATXI) climbed 193% to $0.9962 after jumping 36% on Monday. GBS Inc. (NASDAQ: GBS) rose 73.3% to $0.7971 after declining around 9% on...

Via Benzinga

Is SOFI Stock a Buy Right Now? 3 Analysts Weigh In on SoFI Price Predictions. ↗

March 01, 2022

SoFi (SOFI) stock is on the move today and we're taking a look at the most recent price predictions that analysts have for the company.

Via InvestorPlace

Why GoodRX Shares Are Plummeting Today ↗

March 01, 2022

GoodRx Holdings Inc (NASDAQ: GDRX) is plunging Tuesday after the company reported worse-than-expected fourth-quarter financial results and issued guidance below estimates. ...

Via Benzinga

Is GDRX Stock a Buy After Major Plunge? 3 Analysts Weigh In on GoodRx. ↗

March 01, 2022

Prescription drug price-comparison tool GoodRx is suffering major losses today. GDRX is down big after failing to beat earnings estimates.

Via InvestorPlace

Mid-Morning Market Update: Markets Open Lower; Target Posts Upbeat Earnings ↗

March 01, 2022

U.S. stocks opened on a downbeat note this morning, amid the ongoing Russia-Ukraine conflict. Following the market opening Tuesday, the Dow traded down 0.81% to 33,616.69 while...

Via Benzinga

Where GoodRx Holdings Stands With Analysts ↗

March 01, 2022

Over the past 3 months, 7 analysts have published their opinion on GoodRx Holdings (NASDAQ:GDRX) stock. These analysts are typically employed by large Wall Street banks and tasked...

Via Benzinga

Stocks That Hit 52-Week Lows On Tuesday ↗

March 01, 2022

During Tuesday's trading, 98 companies set new 52-week lows. Intriguing Points From Today's 52-Week Lows And Highs: JPMorgan Chase (NYSE:JPM) was the...

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For March 1, 2022 ↗

March 01, 2022

Upgrades Stifel upgraded the previous rating for Revolution Medicines Inc (NASDAQ:RVMD) from Hold to Buy. For the fourth quarter, Revolution Medicines had an EPS of $0.71,...

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

March 01, 2022

Gainers Avenue Therapeutics (NASDAQ:ATXI) shares rose 102.3% to $0.69 during Tuesday's pre-market session. The market value of their outstanding shares is at $14.3...

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday ↗

March 01, 2022

Good morning, investor! It's time to get into the thick of it with a dive into the biggest pre-market stock movers for Tuesday!

Via InvestorPlace

10 Biggest Price Target Changes For Tuesday ↗

March 01, 2022

Keybanc cut the price target on Workday, Inc. (NASDAQ: WDAY) from $345 to $312. Workday shares rose 5.7% to $242.00 in pre-market trading.

Via Benzinga

27 Stocks Moving in Monday's Pre-Market Session ↗

March 01, 2022

Gainers Avenue Therapeutics, Inc. (NASDAQ: ATXI) rose 123.4% to $0.76 in pre-market trading after jumping 36% on Monday. American Rebel Holdings, Inc. (NASDAQ: AREB) rose 28.6...

Via Benzinga

< Previous 1 2

...

16 17 18 19 20 21 22 23 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.